<SEC-DOCUMENT>0001641172-25-000506.txt : 20250325
<SEC-HEADER>0001641172-25-000506.hdr.sgml : 20250325
<ACCEPTANCE-DATETIME>20250325070533
ACCESSION NUMBER:		0001641172-25-000506
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250325
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250325
DATE AS OF CHANGE:		20250325

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanara MedTech Inc.
		CENTRAL INDEX KEY:			0000714256
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				592220004
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39678
		FILM NUMBER:		25765812

	BUSINESS ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
		BUSINESS PHONE:		817-529-2300

	MAIL ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WOUND MANAGEMENT TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20080611

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MB SOFTWARE CORP
		DATE OF NAME CHANGE:	19960805

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INAV TRAVEL CORPORATION
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:SMTI="http://sanaramedtech.com/20250325">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_030_SMTI_sanaramedtech.com_20250325 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20250325_20250325 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000714256 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000004" name="dei:EntityCentralIndexKey">0000714256</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="smti-20250325.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-03-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000714256</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-25</xbrli:startDate>
        <xbrli:endDate>2025-03-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">UNITED
STATES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 35%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">FORM
<span id="xdx_90F_edei--DocumentType_c20250325__20250325_zBuV2flUq7Of"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <b><span id="xdx_909_edei--DocumentPeriodEndDate_c20250325__20250325_z6YO3diAMCti"><ix:nonNumeric contextRef="AsOf2025-03-25" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">March 25, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 100%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_903_edei--EntityRegistrantName_c20250325__20250325_zv673H5Y6vpf"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000011" name="dei:EntityRegistrantName">SANARA
    MEDTECH INC.</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
    name of registrant as specified in its charter)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20250325__20250325_zzWmWhgQYYI1"><ix:nonNumeric contextRef="AsOf2025-03-25" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Texas</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityFileNumber_c20250325__20250325_zltsdveoVN1g"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000013" name="dei:EntityFileNumber">001-39678</ix:nonNumeric></span></b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20250325__20250325_zSaQTgaIbZ37"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000014" name="dei:EntityTaxIdentificationNumber">59-2219994</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or other jurisdiction</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation)</span></span></p></td>
    <td>&#160;</td>
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></p></td>
    <td>&#160;</td>
    <td style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS Employer</span></p>
                                                                                <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20250325__20250325_zp3261lWTo6"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000015" name="dei:EntityAddressAddressLine1">1200
    Summit Avenue</ix:nonNumeric></span>, <span id="xdx_90C_edei--EntityAddressAddressLine2_c20250325__20250325_zwIUgLQymjRi"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 414</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressCityOrTown_c20250325__20250325_znWrMVxN3jwl"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000017" name="dei:EntityAddressCityOrTown">Fort
    Worth</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20250325__20250325_zCuzXeivhPD"><ix:nonNumeric contextRef="AsOf2025-03-25" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressPostalZipCode_c20250325__20250325_zdyBPtLsmVG8"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000019" name="dei:EntityAddressPostalZipCode">76102</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_906_edei--CityAreaCode_c20250325__20250325_zVELp8eBOtm1"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000020" name="dei:CityAreaCode">(817)</ix:nonNumeric></span> <span id="xdx_902_edei--LocalPhoneNumber_c20250325__20250325_z9HxdAZnObD1"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000021" name="dei:LocalPhoneNumber">529-2300</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<div style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not
Applicable</b></span></p>

</div>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_edei--WrittenCommunications_c20250325__20250325_zKfniSrCjCK3"><ix:nonNumeric contextRef="AsOf2025-03-25" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--SolicitingMaterial_c20250325__20250325_zqznoX6vPTS5"><ix:nonNumeric contextRef="AsOf2025-03-25" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--PreCommencementTenderOffer_c20250325__20250325_z0n6qoxHN5ec"><ix:nonNumeric contextRef="AsOf2025-03-25" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--PreCommencementIssuerTenderOffer_c20250325__20250325_zWhwN7SpBoz"><ix:nonNumeric contextRef="AsOf2025-03-25" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 20%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
                                                                                                                          Symbol(s)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20250325__20250325_zGWE25vtbdS6"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--TradingSymbol_c20250325__20250325_zK6bkk5xScG8"><ix:nonNumeric contextRef="AsOf2025-03-25" id="Fact000027" name="dei:TradingSymbol">SMTI</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
    <span id="xdx_901_edei--SecurityExchangeName_c20250325__20250325_zJ9wFay2tXb8"><ix:nonNumeric contextRef="AsOf2025-03-25" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0pt; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_902_edei--EntityEmergingGrowthCompany_c20250325__20250325_zU1IQzT822E8"><ix:nonNumeric contextRef="AsOf2025-03-25" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 2.02</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results of Operations and Financial Condition.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 25, 2025, Sanara MedTech Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial results for the
quarter and year ended December 31, 2024. A copy of the Company&#8217;s press release is furnished as Exhibit 99.1 to this Current Report
on Form 8-K and is incorporated by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this Current Report on Form 8-K, including Exhibit 99.1 furnished hereto, shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject
to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended, or the Exchange Act, except as expressly set forth in such filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item 9.01</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Statements and Exhibits.</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="padding-bottom: 1pt; width: 0.1in">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release issued March 25, 2025 (furnished pursuant to Item 2.02).</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    25, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sanara
    MedTech Inc</b>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Michael D. McNeil</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Michael D. McNeil</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Title:</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Accounting Officer and Chief Administrative Officer </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZS00q3XRpURGrSBFxG+1Ugm2mTGLVI3lLY4s4DAzD/+9/ISZiRUvTIMNpXhZwwLZrtEcosUZGe8HgyNebDMIt8WqcZ2398P7AnAKDgUnjJD0HYbD2xmGVgZxNlZwmKcg0Uwr2WxF99ZxsbSq03ugGtK1gz9SxQa/5NSYc9JMsta+h6ojsDNkMVCxH+Q2JVAnsqNcP4puDoshFNBkmEiumexdci6dH+yVh0WAb6txI/zf6AAQtSog= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex99-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sanara
MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Q4
Net Revenue Increased 49% Year-Over-Year; 2024 Net Revenue Increased 33% Year-Over-Year</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FORT
WORTH, TX, March 25, 2025 (GLOBE NEWSWIRE) - <B>Sanara MedTech Inc</B>. (&ldquo;Sanara,&rdquo; the &ldquo;Company,&rdquo; &ldquo;we,&rdquo;
&ldquo;our&rdquo; or &ldquo;us&rdquo;) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative
technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today
reported its financial results for the fourth quarter and full year ended December 31, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fourth
Quarter 2024 Financial Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            revenue increased 49% to $26.3 million, compared to $17.7 million in the fourth quarter of
                                            2023.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            loss of $1.7 million, compared to net loss of $0.3 million in the fourth quarter of 2023.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
                                            EBITDA<SUP>(1)</SUP> of $0.9 million, compared to $0.4 million in the fourth quarter of 2023.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Full
Year 2024 Financial Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            revenue increased 33% to $86.7 million, compared to $65.0 million in 2023.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
                                            loss of $9.9 million, compared to net loss of $4.4 million in 2023.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
                                            EBITDA<SUP>(1)</SUP> of $2.7 million, compared to $0.1 million in 2023.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><SUP>(1)
</SUP>Adjusted EBITDA is a non-GAAP financial measure. See the discussion and the reconciliations at the end of this release for additional
information.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fourth
Quarter 2024 and Recent Operational Announcements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            October 4, 2024, the Company appointed Mr. Keith Myers to serve as a director on its Board.
                                            Mr. Myers is the chairman and CEO emeritus of LHC Group, one of the largest and highest quality
                                            in-home healthcare providers in the United States.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 21, 2025, the Company announced the execution of an exclusive license and distribution
                                            agreement with, and minority investment in, Biomimetic Innovations Ltd (&ldquo;BMI&rdquo;),
                                            a privately-held medical device company headquartered in Shannon, Ireland. Sanara acquired
                                            the exclusive U.S. marketing, sales, and distribution rights to BMI&rsquo;s OsStic<SUP>&reg;
                                            </SUP>Synthetic Injectable Structural Bio-Adhesive Bone Void Filler, as well as a hardware
                                            agnostic adjunctive internal fixation technology.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            January 21, 2025, the Company announced the expansion of its executive leadership team with
                                            new appointments, effective January 15, 2025. Elizabeth Taylor was appointed to the position
                                            of Chief Financial Officer, succeeding Michael McNeil, who was appointed to serve as Chief
                                            Accounting Officer and Chief Administrative Officer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            2024, the Sanara R&amp;D team submitted 11 provisional patent applications covering innovations
                                            in proprietary antimicrobial technologies and hydrolyzed collagen, including novel formulations,
                                            treatment applications, and key component advancements.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
                                            March 19, 2025, the Company entered into the First Amendment to Term Loan Agreement with
                                            CRG Servicing LLC (&ldquo;CRG&rdquo;), which amended our existing term loan with CRG to provide
                                            for up to two additional borrowings under the term loan, and extended the date by which borrowings
                                            are permitted to occur by December 31, 2025.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Management
Comments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Our
team delivered an impressive conclusion to 2024, with net revenue growth in the fourth quarter of 49% year-over-year, fueled primarily
by sales of soft tissue products in our Sanara Surgical segment,&rdquo; stated Ron Nixon, Sanara&rsquo;s Executive Chairman and CEO.
&ldquo;Throughout 2024, our Sanara Surgical commercial team achieved strong execution with respect to our growth strategy, expanding
our coverage and penetration of the markets we serve. We also made significant progress in developing the technology platform and infrastructure
for Tissue Health Plus, our value-based wound care program. In parallel, we continued our efforts to evaluate and pursue new partnerships,
enhance our intellectual property portfolio and develop our product pipeline, while securing a new credit facility to provide increased
financial flexibility as we pursue our long-term strategy.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Nixon continued: &ldquo;Looking ahead, our team remains focused on driving revenue growth and improving profitability in our Sanara Surgical
segment, while continuing to invest in our Tissue Health Plus segment. In 2025, we remain focused on improving the profitability in our
Sanara Surgical segment, while continuing to invest in our Tissue Health Plus segment in preparation for a planned launch of our first
pilot program with a wound care provider group during the second quarter. Specifically, we expect our continued investment in Tissue
Health Plus over the first half of 2025 to be between $7.5 to $10.0 million. Importantly, we are pursuing financial partners to invest
in the execution of our Tissue Health Plus strategy. We look forward to expanding awareness and adoption of our technologies this year,
with the goal of improving patient outcomes, reducing healthcare costs and enhancing the long-term value of our organization.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fourth
Quarter and Full Year 2024 Revenue</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables summarize revenue streams from product sales and royalties for the three and twelve months ended December 31, 2024 and
2023:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Three Months Ended</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December 31,</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$ Change</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%; text-align: left">Soft tissue repair</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">23,538,066</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">15,079,871</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">8,458,195</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">56</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Bone fusion products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,767,299</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,559,692</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">207,607</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Royalty revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">50,250</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(50,250</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(100</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Net Revenue</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">26,305,365</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">17,689,813</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">8,615,552</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">49</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="14" STYLE="border-bottom: Black 1pt solid; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year Ended</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December 31,</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">$ Change</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">%</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%; text-align: left">Soft tissue repair</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">76,125,012</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">54,836,410</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">21,288,602</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">39</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Bone fusion products</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,547,413</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,952,432</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">594,981</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Royalty revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">201,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(201,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">(100</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Net Revenue</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">86,672,425</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">64,989,842</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">21,682,583</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">33</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fourth
Quarter 2024 Financial Results</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
revenue for the fourth quarter of 2024 was $26.3 million, compared to $17.7 million for the fourth quarter of 2023, an increase of $8.6
million, or 49%, year-over-year. The increase in net revenue was driven by an increase of $8.5 million, or 56%, in sales of soft tissue
repair products and an increase of $0.2 million, or 8%, in sales of bone fusion products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
increase in sales of soft tissue repair products was driven primarily by increased demand for CellerateRX<SUP>&reg;</SUP> Surgical Activated
Collagen<SUP>&reg;</SUP> (&ldquo;CellerateRX Surgical&rdquo;) and, to a lesser extent, BIASURGE<SUP>&reg;</SUP> Advanced Surgical Solution
(&ldquo;BIASURGE&rdquo;). Fourth quarter 2024 BIASURGE<SUP>&reg;</SUP> sales were driven, in part, by approximately $1.8 million of revenue
that we believe is attributable to supply chain issues and shortages of intravenous fluids and saline solutions experienced by the broader
industry due to Hurricane Helene.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
profit for the fourth quarter of 2024 was $24.1 million, compared to $15.9 million for the fourth quarter of 2023, an increase of $8.2
million, or 51%, year-over-year. The increase in gross profit was driven by increased sales of soft tissue repair and bone fusion products.
Gross margin was 91% of net revenue for the fourth quarter of 2024, compared to 90% of net revenue for the fourth quarter of 2023. The
increase in gross margin was driven by increased sales of soft tissue repair products, particularly CellerateRX<SUP>&reg;</SUP> Surgical
and BIASURGE<SUP>&reg;</SUP>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
expenses for the fourth quarter of 2024 were $24.4 million, compared to $16.1 million for the fourth quarter of 2023, an increase of
$8.3 million, or 51%, year-over-year. The increase in operating expenses was driven by an increase of $6.1 million, or 37%, in selling,
general and administrative (&ldquo;SG&amp;A&rdquo;), an increase of $1.8 million, or 270%, in research and development (&ldquo;R&amp;D&rdquo;),
and an increase of $0.5 million, or 47%, in depreciation and amortization. The increase in depreciation and amortization in the fourth
quarter of 2024 was driven by a $0.5 million non-cash charge to write-off the remaining net book value of certain Tissue Health Plus
internal use software assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
loss for the fourth quarter of 2024 was $0.4 million, compared to operating loss of $0.2 million for the fourth quarter of 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
expense for the fourth quarter of 2024 was $1.3 million, compared to $36,449 for the fourth quarter of 2023. Other expense for the fourth
quarter of 2024 primarily included higher interest expense related to the Company&rsquo;s term loan with CRG.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss for the fourth quarter of 2024 was $1.7 million compared to a net loss of $0.3 million for the fourth quarter of 2023. The Company&rsquo;s
Sanara Surgical segment generated net income of $0.9 million for the fourth quarter of 2024, compared to a net loss of $0.7 million for
the fourth quarter of 2023. The Company&rsquo;s Tissue Health Plus segment generated a net loss of $2.6 million for the fourth quarter
of 2024, compared to net income of $0.5 million for the fourth quarter of 2023. The year-over-year increase in net loss in the Company&rsquo;s
Tissue Health Plus segment was primarily due to higher SG&amp;A and R&amp;D related to the buildout of the Tissue Health Plus platform
and infrastructure, and higher depreciation and amortization related to a $0.5 million non-cash charge in the fourth quarter of 2024
to write-off the remaining net book value of certain Tissue Health Plus internal use software assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
EBITDA<SUP>(1)</SUP> for the fourth quarter of 2024 was $0.9 million, compared to $0.4 million for the fourth quarter of 2023. The Company&rsquo;s
Sanara Surgical segment generated Segment Adjusted EBITDA<SUP>(2)</SUP> of $4.1 million for the fourth quarter of 2024, compared to $1.5
million for the fourth quarter of 2023. The Company&rsquo;s Tissue Health Plus segment generated Segment Adjusted EBITDA<SUP>(2)</SUP>
of ($3.1) million for the fourth quarter of 2024, compared to ($1.1) million for the fourth quarter of 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2024, Sanara had $15.9 million of cash and $30.5 million of principal debt obligations outstanding, and $24.5 million
of available borrowing capacity, compared to $5.1 million, $9.8 million, and $2.3 million, respectively, as of December 31, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Full
Year 2024 Financial Results</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
revenue for the full year 2024 was $86.7 million, compared to $65.0 million for the full year 2023, an increase of $21.7 million, or
33%, year-over-year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
loss for the full year 2024 was $9.9 million compared to net loss of $4.4 million for the full year 2023. The Company&rsquo;s Sanara
Surgical segment generated a net loss of $1.9 million for the full year 2024, compared to net income of $0.4 million for the for full
year 2023. The year-over-year change in net loss in the Company&rsquo;s Sanara Surgical segment was driven primarily by interest expense
of $3.2 million, compared to $0.2 million for the full year 2023. The Company&rsquo;s Tissue Health Plus segment generated a net loss
of $8.0 million for the full year 2024, compared to a net loss of $4.9 million for full year 2023. The year-over-year change in net loss
in the Company&rsquo;s Tissue Health Plus segment was primarily due to higher SG&amp;A and R&amp;D related to the buildout of the Tissue
Health Plus platform and infrastructure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
EBITDA<SUP>(1)</SUP> for the full year 2024 was $2.7 million, compared to $0.1 million for the full year 2023. The Company&rsquo;s Sanara
Surgical segment generated Segment Adjusted EBITDA<SUP>(2)</SUP> of $9.1 million for the full year 2024, compared to $5.3 million for
the full year 2023. The Company&rsquo;s Tissue Health Plus segment generated Segment Adjusted EBITDA<SUP>(2)</SUP> of ($6.5) million
for the full year 2024, compared to ($5.2) million for the full year 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><SUP>(1)
</SUP>Adjusted EBITDA is a non-GAAP financial measure. See the discussion and the reconciliations at the end of this release for additional
information.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I><SUP>(2)
</SUP>Segment Adjusted EBITDA is a non-GAAP financial measure. See the discussion and the reconciliations at the end of this release
for additional information.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Conference
Call</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
will host a conference call on Tuesday, March 25, 2025, at 8:00 a.m. Eastern Time to discuss the results for the quarter and full year
ended December 31, 2024, and hold a question and answer session at the end of the call. The toll-free number to call for this teleconference
is 888-506-0062 (international callers: 973-528-0011) and the access code is 904042. A telephonic replay of the conference call will
be available through Tuesday, April 08, 2025, by dialing 877-481-4010 (international callers: 919-882-2331) and entering the replay passcode:
52172.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
live webcast of Sanara&rsquo;s conference call will be available under the Investor Relations section of the Company&rsquo;s website,
<FONT STYLE="background-color: white"><U>www.SanaraMedTech.com</U></FONT>. A one-year online replay will be available after the conclusion
of the live broadcast.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Sanara MedTech Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical
outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. The Company markets, distributes and
develops surgical, wound and skincare products for use by physicians and clinicians in hospitals, clinics and all post-acute care settings
and offers wound care and dermatology virtual consultation services via telemedicine. Sanara&rsquo;s products are primarily sold in the
North American advanced wound care and surgical tissue repair markets. Sanara markets and distributes CellerateRX<SUP>&reg;</SUP> Surgical
Activated Collagen<SUP>&reg;</SUP>, FORTIFY TRG<SUP>&reg;</SUP> Tissue Repair Graft and FORTIFY FLOWABLE<SUP>&reg;</SUP> Extracellular
Matrix as well as a portfolio of advanced biologic products focusing on ACTIGEN<SUP>TM</SUP> Verified Inductive Bone Matrix, ALLOCYTE<SUP>&reg;
</SUP>Plus Advanced Viable Bone Matrix, BiFORM<SUP>&reg;</SUP> Bioactive Moldable Matrix, TEXAGEN<SUP>&reg;</SUP> Amniotic Membrane Allograft,
and BIASURGE<SUP>&reg;</SUP> Advanced Surgical Solution to the surgical market. In addition, the following products are sold in the wound
care market: BIAK&#332;S<SUP>&reg;</SUP> Antimicrobial Skin and Wound Cleanser, BIAK&#332;S<SUP>&reg;</SUP> Antimicrobial Wound Gel,
and BIAK&#332;S<SUP>&reg;</SUP> Antimicrobial Skin and Wound Irrigation Solution. Sanara&rsquo;s pipeline also contains potentially
transformative product candidates for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization and closure, necrotic
tissue debridement and cell compatible substrates. The Company believes it has the ability to drive its pipeline from concept to preclinical
and clinical development while meeting quality and regulatory requirements. Sanara is constantly seeking long-term strategic partnerships
with a focus on products that improve outcomes at a lower overall cost. For more information, please visit sanaramedtech.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
about Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
statements in this press release that do not constitute historical facts are &ldquo;forward-looking statements,&rdquo; within the meaning
of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements may be identified
by terms such as &ldquo;aims,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; contemplates,&rdquo; &ldquo;continue,&rdquo;
&ldquo;could,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expect,&rdquo; &ldquo;forecast,&rdquo; &ldquo;guidance,&rdquo; &ldquo;intends,&rdquo;
&ldquo;may,&rdquo; &ldquo;plans,&rdquo; &ldquo;possible,&rdquo; &ldquo;potential,&rdquo; &ldquo;predicts,&rdquo; &ldquo;preliminary,&rdquo;
&ldquo;projects,&rdquo; &ldquo;seeks,&rdquo; &ldquo;should,&rdquo; &ldquo;targets,&rdquo; &ldquo;will&rdquo; or &ldquo;would,&rdquo;
or the negatives of these terms, variations of these terms or other similar expressions. These forward-looking statements include, among
others, statements regarding the timing of our planned commercial launch of the Company&rsquo;s Tissue Health Plus platform, the Company&rsquo;s
business strategy and mission, the development of new products, the timing of commercialization of the Company&rsquo;s products, the
regulatory approval process and expansion of the Company&rsquo;s business into value-based skincare, wound care and other services. These
items involve risks, contingencies and uncertainties such as uncertainties associated with the development and process for obtaining
regulatory approval for new products, the Company&rsquo;s ability to build out its executive team, the Company&rsquo;s ability to identify
and effectively utilize the net proceeds of its term loan to support the Company&rsquo;s growth initiatives, the extent of product demand,
market and customer acceptance, the effect of economic conditions, competition, pricing, uncertainties associated with the development
and process for obtaining regulatory approval for new products, the ability to consummate and integrate acquisitions, and other risks,
contingencies and uncertainties detailed in the Company&rsquo;s SEC filings, which could cause the Company&rsquo;s actual operating results,
performance or business plans or prospects to differ materially from those expressed in, or implied by these statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to revise any of
these statements to reflect future circumstances or the occurrence of unanticipated events, except as required by applicable securities
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
Powell or Mike Piccinino, CFA ICR Healthcare</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>IR@sanaramedtech.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SANARA
MEDTECH INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
BALANCE SHEETS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<BR> 2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,<BR> 2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; width: 60%">Cash</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">15,878,295</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">5,147,216</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,408,819</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,474,965</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts receivable &ndash; related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,566</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,400</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Royalty receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">49,344</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Inventory, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,753,032</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,717,533</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Convertible loan receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,101,478</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Prepaid and other assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,123,798</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">608,411</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total current assets</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">33,305,988</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">19,005,869</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Long-term assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Intangible assets, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,006,776</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,926,061</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,601,781</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,601,781</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Investment in equity securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,297,223</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,084,278</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Right of use assets &ndash; operating leases</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,447,907</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,995,204</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Property and equipment, net</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">432,317</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,257,956</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total long-term assets</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">54,786,004</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">54,865,280</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">88,091,992</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">73,871,149</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center">Liabilities and shareholders&rsquo; equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,499,764</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,924,082</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable &ndash; related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,913</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,805</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accrued bonuses and commissions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,778,840</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,676,770</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accrued royalties and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,621,867</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,047,678</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Earnout liabilities &ndash; current</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">748,001</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,100,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Current portion of debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">580,357</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Operating lease liabilities &ndash; current</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">358,687</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">361,185</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total current liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">16,038,072</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">13,767,877</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Long-term liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Long-term debt, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,689,290</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,113,123</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Earnout liabilities &ndash; long-term</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,723,001</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Operating lease liabilities &ndash; long-term</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,237,051</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,737,445</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other long-term liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,215,617</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,941,686</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total long-term liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">33,141,958</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">15,515,255</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total liabilities</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">49,180,030</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">29,283,132</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Shareholders&rsquo; equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Common Stock: $0.001 par value, 20,000,000 shares authorized; 8,753,773 issued and outstanding as of December 31, 2024 and 8,535,239 issued and outstanding as of December 31, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,754</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,535</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,179,211</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">72,860,556</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(37,784,392</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(28,036,814</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Total Sanara MedTech shareholders&rsquo; equity</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">39,403,573</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">44,832,277</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Equity attributable to noncontrolling interest</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(491,611</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(244,260</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total shareholders&rsquo; equity</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">38,911,962</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">44,588,017</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total liabilities and shareholders&rsquo; equity</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">88,091,992</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">73,871,149</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SANARA
MEDTECH INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF OPERATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Three Months Ended</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December 31,</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year Ended December 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%; font-weight: bold; text-align: left">Net Revenue</TD><TD STYLE="width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 12%; font-weight: bold; text-align: right">26,305,365</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 12%; font-weight: bold; text-align: right">17,689,813</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 12%; font-weight: bold; text-align: right">86,672,425</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left">$</TD><TD STYLE="width: 12%; font-weight: bold; text-align: right">64,989,842</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Cost of goods sold</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">2,249,182</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">1,788,162</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">8,139,901</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">7,852,686</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Gross profit</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">24,056,183</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">15,901,651</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">78,532,524</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">57,137,156</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Selling, general and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,416,741</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,336,329</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">76,559,863</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,994,753</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,411,883</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">651,519</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,703,362</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,132,425</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,608,443</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,094,783</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,923,224</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,675,026</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Change in fair value of earnout liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,006,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,954,985</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,938,451</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,449,895</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">24,431,067</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">16,127,646</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">85,247,998</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">61,352,309</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Operating loss</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(374,884</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(225,995</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(6,715,474</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">(4,215,153</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Other income (expense)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,289,136</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(287,483</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,128,395</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(475,783</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Share of losses from equity method investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(58,559</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(90,007</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,978</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,978</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Gain on disposal of investment</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">251,034</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">251,034</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Total other income (expense)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(1,325,717</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(36,449</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(3,196,424</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(224,749</TD><TD STYLE="font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net loss</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(1,700,601</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(262,444</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(9,911,898</TD><TD STYLE="font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">(4,439,902</TD><TD STYLE="font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Less: Net loss attributable to noncontrolling interest</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(162,020</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(25,250</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(247,351</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(136,705</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net loss attributable to Sanara MedTech shareholders</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,538,581</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(237,194</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(9,664,547</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(4,303,197</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net loss per share of common stock, basic and diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.18</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.03</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1.14</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(0.52</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Weighted average number of common shares outstanding, basic and diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,531,507</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,356,886</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,484,224</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,278,949</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SANARA
MEDTECH INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CONSOLIDATED
STATEMENTS OF CASH FLOWS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Year Ended December 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; text-align: left">Net loss</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">(9,911,898</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">(4,439,902</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,923,224</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,675,026</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Credit loss expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">624,448</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">202,941</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Inventory obsolescence</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">521,757</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">406,812</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Share-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,436,048</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,442,722</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Noncash lease expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">547,297</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">342,972</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Share of losses from equity method investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,007</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Gain on disposal of investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(251,034</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Back-end fee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">358,086</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Paid-in-kind interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">838,965</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accretion of finance liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">210,931</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">98,926</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Amortization and write-off of debt issuance costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">209,499</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,138</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Change in fair value of earnout liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,938,451</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,449,895</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accrued interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,978</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,508,958</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,821,895</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts receivable &ndash; related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32,166</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,148</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Inventory, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,442,744</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,545,339</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Prepaid and other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(515,496</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">496,200</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(424,318</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">531,380</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accounts payable &ndash; related parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(46,891</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,768</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Accrued royalties and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">574,189</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(739,645</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Accrued bonuses and commissions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,102,069</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(81,513</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Operating lease liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(502,892</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(252,366</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(23,784</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(3,245,556</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from investing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Purchases of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(205,848</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(265,246</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Purchases of intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(23,452</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Proceeds from disposal of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">650</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Investment in equity securities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,302,952</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Convertible loan receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,079,391</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Acquisitions, net of cash acquired</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(9,942,750</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,611,643</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(10,207,346</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Cash flows from financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Loan proceeds, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,339,260</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,688,341</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Pay off line of credit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(9,750,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Equity offering net proceeds (expenses)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(75,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">911,371</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Net settlement of equity-based awards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(125,205</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(135,794</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Cash payment of finance and earnout liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,022,549</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(822,795</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,366,506</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,641,123</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net increase (decrease) in cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,731,079</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,811,779</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; padding-bottom: 1pt">Cash, beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,147,216</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,958,995</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt">Cash, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,878,295</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,147,216</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Cash paid during the period for:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,580,984</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">283,948</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental noncash investing and financing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Right of use assets obtained in exchange for lease obligations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,531,773</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Equity issued for acquisitions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,089,645</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Earnout and other liabilities generated by acquisitions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,759,642</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SANARA
MEDTECH INC. AND SUBSIDIARIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NON-GAAP
FINANCIAL MEASURES (UNAUDITED)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
supplement the Company&rsquo;s financial information presented in accordance with generally accepted accounting principles in the United
States (&ldquo;GAAP&rdquo;), we present certain non-GAAP financial measures in this press release and on the related teleconference call,
including Adjusted EBITDA and Segment Adjusted EBITDA. The Company&rsquo;s management uses these non-GAAP financial measures, both internally
and externally, to assess and communicate the financial performance of the Company. The Company defines Adjusted EBITDA as net income
(loss) excluding interest expense/income, provision/benefit for income taxes, depreciation and amortization, non-cash share-based compensation
expense, change in fair value of earnout liabilities, share of losses from equity method investments, executive separation costs, legal
and diligence expenses related to acquisitions, and gains/losses on the disposal of property and equipment, as each is applicable to
the periods presented. Segment Adjusted EBITDA is calculated in the same manner as Adjusted EBITDA but is presented on a segment basis.
The Company has historically presented Segment Adjusted EBITDA as Segment EBITDA, and starting with the fourth quarter ended December
31, 2024, is presenting it as Segment Adjusted EBITDA. The definition and methodology for calculating this measure has remained unchanged.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes Adjusted EBITDA and Segment Adjusted EBITDA are useful to investors because they facilitate comparisons of its core
business operations across periods on a consistent basis. Accordingly, the Company adjusts for certain items, such as change in fair
value of earnout liabilities, when calculating Adjusted EBITDA and Segment Adjusted EBITDA because the Company believes that such items
are not related to the Company&rsquo;s core business operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s non-GAAP financial measures are not in accordance with, nor an alternative for, measures conforming to GAAP and may be
different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any
comprehensive set of accounting rules or principles. The Company continues to provide all information required by GAAP, but it believes
that evaluating its ongoing operating results may not be as useful if an investor or other user is limited to reviewing only GAAP financial
measures. The Company does not, nor does it suggest that, investors should consider these non-GAAP financial measures in isolation from,
or as a substitute for, financial information prepared in accordance with GAAP. Material limitations associated with the use of such
measures include that they do not reflect all costs included in operating expenses and may not be comparable with similarly named financial
measures of other companies. Furthermore, these non-GAAP financial measures are based on subjective determinations of management regarding
the nature and classification of events and circumstances. The Company presents these non-GAAP financial measures to provide investors
with information to evaluate the Company&rsquo;s operating results in a manner similar to how management evaluates business performance.
To compensate for any limitations in such non-GAAP financial measures, management believes that it is useful in understanding and analyzing
the results of the business to review both GAAP information and the related non-GAAP financial measures. Whenever the Company uses a
non-GAAP financial measure, it provides a reconciliation of the non-GAAP financial measure to the most directly comparable GAAP financial
measure. Investors are encouraged to review and consider these reconciliations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Segment
Adjusted EBITDA is reported to the chief operating decision maker for purposes of making decisions about allocating resources to the
segments and assessing their performance. We have provided a reconciliation of this measure as it relates to our segments below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reconciliation
of Net Income (Loss) to Segment Adjusted EBITDA and Adjusted EBITDA:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="22" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Three Months Ended December 31,</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2024</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2023</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Sanara Surgical</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">THP</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Total</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Sanara Surgical</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">THP</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Total</TD><TD STYLE="padding-bottom: 1pt; text-align: center; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Net Income (Loss)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">934,704</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">(2,635,304</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">(1,700,600</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">(740,810</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">478,366</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">(262,444</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Adjustments:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,289,136</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,289,136</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">287,483</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">287,483</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,978</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,978</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization <SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">692,032</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">916,411</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,608,443</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">687,679</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">407,104</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,094,783</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Noncash share-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,165,472</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,214</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,195,686</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">777,994</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">82,565</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">860,559</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Change in fair value of earnout liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,006,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,006,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,578</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,042,563</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,954,985</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Share of losses from equity method investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,559</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,559</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Executive separation costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition costs <SUP>(2)</SUP></FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(64,872</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">587,368</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">522,496</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">423,513</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">423,513</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Segment Adjusted EBITDA (on a segment basis) / Adjusted EBITDA (consolidated)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,053,053</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,107,311</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">945,742</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,523,437</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(1,074,528</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">448,909</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Net Revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">26,305,365</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">26,305,365</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">17,689,813</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">17,689,813</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net Income (Loss) as a % of Net Revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">3.6%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">N/A</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">(6.5)%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">(4.2)%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">N/A</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">(1.5)%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Segment Adjusted EBITDA (on a segment basis) / Adjusted EBITDA (consolidated)
    as a % of Net Revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">15.4%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">N/A</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">3.6%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">8.6%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">N/A</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: center">2.5%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            a $506,836 non-cash charge during the fourth quarter of 2024 to write-off the remaining net
                                            book value of certain Tissue Health Plus internal use software assets.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition
                                            costs include legal, tax and accounting services related to prospective acquisitions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="22" STYLE="text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year
Ended December 31,</B></FONT></P></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2024</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2023</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Sanara Surgical</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">THP</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Sanara Surgical</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">THP</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">Net Income (Loss)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">(1,937,583</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">(7,974,315</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">(9,911,898</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">440,485</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">(4,880,387</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 6%; text-align: right">(4,439,902</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Adjustments:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,128,395</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,128,395</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">475,783</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">475,783</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,978</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,978</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation and amortization <SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,785,829</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,137,395</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,923,224</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,046,859</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,628,167</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,675,026</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Noncash share-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,969,008</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">138,245</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,107,253</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,201,330</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">241,392</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,442,722</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left">Change in fair value of earnout liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(14,451</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,924,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,938,451</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,298,336</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,151,559</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,449,895</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Share of losses from equity method investments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,007</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">90,007</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive separation costs <SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">964,466</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">964,466</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition costs <SUP>(3)</SUP></FONT></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">185,029</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,165,260</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,350,289</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">423,513</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">423,513</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Segment Adjusted EBITDA (on a segment basis) / Adjusted EBITDA (consolidated)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">9,148,722</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(6,457,415</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,691,307</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,289,634</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(5,162,387</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">127,247</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            a $506,836 non-cash charge during the fourth quarter of 2024 to write-off the remaining net
                                            book value of certain Tissue Health Plus internal use software assets.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
                                            $328,795 of share-based compensation related to executive separation costs for the twelve
                                            months ended December 31, 2024.</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition
                                            costs include legal, tax and accounting services related to prospective acquisitions.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 31.5pt; text-indent: -13.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !D 2P# 2(  A$! Q$!_\0
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ML%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF2X',*DXX/#XFGA:;6(J1E"G0T:BV[K\XXUQ_#GU3BJ&<\49!2S/A:EEG%6
MP^?8&CF$. LQH4IX/(.(ZF5Y;4P^.Q>%KXC%3Q=L?4J55BZ]:EEZCA;I_-VM
MW'@;]KC7_P!C'_@JM#^V=\8?V4_V>_@+#XRB\7? OQ)JECX?^'GQ U5_%&J^
M%KK0/'5SI?CF+0&OM2U>VNO#^HR'0/B&GB_P[#HMGX?'AS5X9[V;0\-?L]_L
MR>#_ /@H9X7_ &]I?VX?!$EY^TAIFI1_!SX5ZAXG\'Z5>_$L:SX5T[PI)8^!
M?$UUX_?4_B)X'L;C['?:=X(T3PA(]EXH?0M--Y)=VZ6TOXP_M7_\%&_&'[0'
M[<'P0_X)?^&OV2_#VB_L3?%75OV8F^'/AGPKX2UGX??'0>#_ (F>&/!_CC2O
MC/\ #BZTB_\ ^%<>#=,^&]MXJU@3^%[SP1XA\'Z?I7A[Q;%X@U2UUI7NM*\T
M_:+_ .">W[#G[=?[0N@/^S/^V/XO^&O@;]D?]G8Z/XV\+>*/A5K_ (Q\5^.?
MAK\ O%WBCQGXK^)7[/\ XWMO$7AVT\0^+=4NO$NN:W/976EVEHNO75GXB\,:
M1<Z*;J'0ONL-E%? 8;,:V%Q'$&1TL;@LQI8K+Z&5Y9G^%RS@O&XF4,%A,WS'
M#JIBXYE6Q\:F$JUYJG6I6^LTZL*=Y1^$QF;T\VS;AO#YW#A#.Z='$Y3F>19Q
M5S?/L@S#/O$C!4H5\ZS'*,AKXEX7%Y'2X=E#'T,!.KB,/%N]:ASSC37[??LX
M_$G]E/\ X*3?"']N+]GC]GGX5>(/V5YO&;V^L^/?&>A>%_"^DZKXUO/'>HZW
M;6?C/5[3POJ=M)>ZEJ-SX<N;#Q3X+UV^M8;CPYJU_H]EJ^;K4)],W=!_94^&
M/P:_9<TG_@F';?MXCX<_'+QSXBE^(OAO5M#FC\+>,KBUN_$-OXC?PEX5^&NG
M>/-/U.V\):U:Z-=QC1[/QC8WOB6XBUG7;&*YD.M:=;^ _P#!+C_@MW^R[^UI
MXD_:TB;]G#3/V,])^&/P[\1_M6>.O&L&H^'/$F@^-OAWH^M16'C;QQ\2-1\'
M^!O"VH6GQ"TEM9T;4)K)CX\N_$T5_K']F:[-<:9,NJ_ ?[;_ /P4*_8L^+W@
M#Q%_P55_8:\-^/\ XK_M-_L\_%/X+_#OQQX4^*^A^*_#/P]^&^DZY:^-V^'G
M[1?Q&^'FGSVFJZYX>@O/"[^#/#=QHOCO0M.7Q;K'AUOB%I;26R6.HY499A4S
MW,<FP]'B3AC(:&*RS-\LP.)AE?$-;#\71RS#X/)*N<9WF5.IR9?CZD)<JG6>
M&P.'5'VF'<HWC>+R6E'AS*<ZJ+A+B_BJKA,WX<S3'4<1G7!N"GP/FV>YEB.*
M*&493D-;"XBKFN%P%?#T\-6HT5B:F/A4Q%"O3E.;G^X?CC]JSX!77QCT/_@D
MS\4;+XQ?$?7/%'PS\+?"CQ=\6K[^RK.UU[Q#JWPQM]?L;G6[VQU>+Q3/K_B3
M1;&#Q!J7B/3=)N-$LM?O4LKY);2PU24?I;\%/A+X!^!WPP\'_";X?075IX0\
M&:*VDZ5'>ZI-J=\J3W$FI7TM[?R/O$UW>W=S>3%%MH$><I9VEK:1PP1_RZ?"
M#_@OI\'[+P_^P5\7OVN_V*3;?M4?M+-XF\('XR_#7X=:*!I'PGMOBA<?"/0_
M'_@*X\46^J_$W7]"\6ZZ]Y#=_#/PSKU[<PQZ7K$^DWFJPZYX7T35_P!:/#VN
M?LB?\$W/VDOB!X:\8_'3XKW/Q+_;I^)\'Q&'AWQD=5\8^$? ]UK/B?Q!IFES
M17^E:*\7AK3M;\2^('\+IK&OWNJ:I>P:#I-KJ%U#HVB2ZDWSV9Y-BZ^&H97E
MN"SK"XN&"JYK6RVAS9_AN*.(<MQ53"Y]GN ^IS]EE6#P>7)UHJK%^XOW=I64
M_ILJS+#Y1F\N)<ZQW"F(P]7,/["P?$E6E_JSC>$.$,QPV3XGASA?,*F;8^K4
MS_'YAGW[JV%M*-><:\Y.$I'ZW/>PV*WIFN[:SL[.(RM-<RK%%#$D*RW%Q-<3
M!8DB@W,\TLDK1HH+2% "11@UQKG4+>TM!=7MG<Z7#JT.M6UO#/H5Q;3S>5'#
M;ZG"6BEOGC,5[#"F89["87*RE0M?'/A_P/\ M$>.OC%^T3X2^/NG?#/Q%^R7
MXR\/1>'OAYH6GH#XJODO;*WM-6TWQ#-#%;ZDT<NCW.N6FM3:M?W-Q!J*6O\
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M?3]/TG2-.@GO[[4-1OKJ:&SLK'3[.">XO+RXECM[6U@DGED\N-FK^.;]LO\
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M2:5<7.F7J77X3_\ !1[]IO\ ;P_:/N_V9--_X),_"KQKXV_8K\*>&].\$1^
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M2_;5^)7[.OPS_;$\%V'B7_@I#^SW\(?"6J?%"1M"\1>'_#&E?%[PCI>C:O\
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MD6[0!C.DWA#QSIOC+3Y]9@.QOL,,'ANV:&.96NK8MYI_HY_X)_?\%KOV'_\
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MFN/AG\/?!VH3Q1SZ'IE[X.30_%OC);8R7.L^*]:O]/U'4M9T?0_#<EC\;?\
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M\4)XFTWXI>,]&\,?$76]/M;WQ!8:MK6@V7AS5--@\-Q:-J-G:W5A!':6=O\
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M;2/QG>>'H:_0#QG\ ?B[^W+^R)X*_:I\,_ 7X.?LZ?\ !1K5-.TN"T^*>J^
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M_LN=&\0Z1%::?J,@33K1J^"?AM_P2].E?\%?_B=_P4ML?VP]3\5:-J&F>(=
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M^'+:O!IMPWP\\)%-*T[[-X1T 2P2Z/;/]NCBCO8D,\DMN\USB_L_?LF?!O\
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<4 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>smti-20250325.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa+JWbP9z5Z8SekhvWB3bVnaryEk5cvlPCFOMTNm4TcO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:SMTI="http://sanaramedtech.com/20250325" elementFormDefault="qualified" targetNamespace="http://sanaramedtech.com/20250325">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://sanaramedtech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="smti-20250325_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="smti-20250325_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>smti-20250325_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>smti-20250325_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sanaramedtech.com/role/Cover" xlink:href="smti-20250325.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sanaramedtech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 25, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 25,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANARA
    MEDTECH INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000714256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-2219994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200
    Summit Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort
    Worth<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">76102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(817)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">529-2300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SMTI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *\X>5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( *\X>5IU2CJ5[@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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M%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B+7D%=*RHC_#K3),
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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M/UY_ 5!+ 0(4 Q0    ( *\X>5I&QTU(E0   ,T    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ KSAY6G5*.I7N
M*P(  !$              ( !PP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ KSAY6IE<G",0!@  G"<  !,              ( !X $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " "O.'E:%?486F,$   E$0  &
M            @($A"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ KSAY6I^@&_"Q @  X@P   T              ( !N@P  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " "O.'E:EXJ[',     3 @  "P
M    @ &6#P  7W)E;',O+G)E;'-02P$"% ,4    " "O.'E:JL0B%C,!   B
M @  #P              @ %_$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ KSAY6B0>FZ*M    ^ $  !H              ( !WQ$  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ KSAY6F60>9(9 0  SP,
M !,              ( !Q!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  D "0 ^ @  #A0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sanaramedtech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>smti-20250325.xsd</File>
    <File>smti-20250325_lab.xml</File>
    <File>smti-20250325_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "SMTI",
   "nsuri": "http://sanaramedtech.com/20250325",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "smti-20250325.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "smti-20250325_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "smti-20250325_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://sanaramedtech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-25",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001641172-25-000506-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-000506-xbrl.zip
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M;4$2PQKP):X6TD'B4&%$;2\>.79(!?IS0GV08$D(/W%]AHLH@:.&9XG@C,(
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M?1ZZ1"N<^B.TE]G3&,6#A0%*="O ^@<[#;8"*PX#SPWXK0W?,OM]2DW"Q)T
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MAKBX!O.7QG>4^L(O1D_CO0/$6=4,',X8!1-(Y!0.M@V4$PCY3)ADXFZ&8$P
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MB.W;<<ZV.147<! I'W<[\<B.L=;]FGK8'(4-4(IY$W76UAP;\":3"2R!PS*
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MX^XR[(: LU30*!.1T^AI;A @UEMM_#@EHJH&L42C+L<I$<O2"'!*\WAS::0
M#S6M9$=^91G^<TJQB:ZRJLA$D0ITLS>A @E(!3A'*]@;+R58X"VQO_?*O]54
ML!/ B"O*HS9<\#1TFCJ(=[-P2=:&"UH7=*V23.YI,UGV9 F6KK(RT['GA$&0
M@!M<D8X+B2#/7SBSV4TB6FA8%6[Q2K>[:3'V(G!J*,0T)"*ICP8^GXK35I;M
MH2S+$E!/75Z\FQ7=1B,[I-B1F8916BB;^OYUQ%R]H-EQ3O%\OJHW.]@ZXJI>
MT-0A4W%BWS\C5:.@@,IC,)9%#'W%D,>&8+%DE8CFBOD^=0B_%,]L5SF)BD@L
MJ38!4L,@IKC----G,UZ88/E[X"=1JOVPZPMO&+/Y@*A(#,,DIKIB&N<&SX_H
M!EYL;3.O=)TLR4XS9*FFF363CK3;^&'*1)<E8NJUB6[+1%3Q/)MS67%LASXV
M^,G9+5.QFJ83;9P!5/!?Q=K<'F)2I0@ -9(?,S,46R:EW:YP?/JF<5:;O&_-
M%(FBK2@/=L9^2T+ 7^<O":OP9A-O6!3-)+JYOS=,B@ZBQBQ8;MN^7UJ/!UPI
M+[7$.=ZKZQ%))R)@630>#=2VMTU5T*F 5PW>CU%-AFPW0KNH%VH<AJD7-#40
M9OGDU#:@MVM+ZJ'30>.6I=JPYK'SQN\6PD"Z:1'9JDTHP2(2R$1IU>2]37/<
M:E[G-"]E;YP6F1BRLKH+O"5FJ^*-;.W,)* S@XA:C:(%!@"DJC6K\Z_J:;+*
M1N\A9==$SPJH1-*(OM?9BY8J@7K:@^S%?7<J%=#X<-:6UE8\KL6IU(@&_X%<
MK:%3V:;]U-1'>;8XVW,AIH+K8HI$5#:4.+QGZ)3!+35!+Q3[NK1"K!5BSVO,
MB+D:,1^0P',W<@-$ZHBJ>D'3<DZ3#^!9G'/9YOC6CVU0G.$HZ#AP?KP3?A%[
MHBAA'B$? 48$F:6"X'\\1QN$7A*/@M#]A\(AFZQ]FF$H IN;EK:+2F*<$,-&
MLO&I-?EVRJR)-/N=230%' W%6NUA9=/G@YO:=*[J"L  DFK X173X=*YZCA]
MSG8'AZXO./;$!0M_TW@R#"(98/45FUOMZN0,F9BZ2+1B!6W]$ZF6^ 1]QTG&
M"<\U'M"AZ[B-3L Y4 QBF"I1'B\<6Q(F?-/H[<LF.)PZ,:5JQ;]+M[\[DX('
M#R[9?"#AC ZNJ#.J4$NT]!T/G]5ZO>ZR4*9%5%$AFE&XP%SGJW>\254EIB(3
MN9BU4ALW?,5;I&/>I,:.X]"]3F)6FA'C#&D?G<,P\' \))M)"?93LR6F:DE$
M?W(#R8:+2Z!<6:\6H*N=K'PP^OH,B?D2HX<@$"Q)(I;>IBFN);:M$@U+]"M>
M1]=."SR_/8.W<K7S"@3R(MH-M"T<UH_3+;9P2,<MOOA!G'H[B'/Z93N(\]$A
MB#-HFC9Q<?\&9EY>P9]GQ^=7E\+7S\+7;\<7_:L3^$7#-YF1X$L=G?F$:9'Z
MJX?$V:-BND&'?S4**17.X)M1)!S[ SI8( 2A2;N9&\HYOX]5J6)=+E@)355J
M@/0XF?U)[9 ?F3"_[Z=X4$_TE[8_N'9-R*O_G-KU;70M8VF;L-'V1+?,Y(]N
M_8'?-_OQ34>44I-)T5]7=+K/:2Q<T%OJ)W21.*8S6A\CB6502%6!6#K)M?3=
MY7F9.IM.I!3'@JX*3#E3-PH9DL'J)\UB*ZT]1(:I$]V0B2JWE/'J@ZX2"RE#
M+41#GX.,MIR_A:9>T-3RYH99?4=!Q$KJ;X)@$*%M-MC+JSN9R*PRI;T(74MI
M'3%,DTCMM?):L F85"QB%;L&M-A\ C8-8FIRY8+IUO9HA'ZM;Q+@DY[=PPW6
MUT+Z$@91)$S"8%A, M\+B8E]Q#4=C*,GQNM:!31O'&FHRXE>;&W3HO,I^AP+
MAV2B/35LWJ)S#IV: =8F_%=Q'%YK'S7$/FJAJ;'ED>^]MJV6^LT_N!::+8G9
M10WP<&GL)65E0$2XH3X0M<<2P>W!V/7=*$8BOWWJ#)[*&)-EHDHZ,=3:U,@"
M-(H"_\F%%.5=063H1-,L8NJUF6\#/H9EJ5AH7R\!7G$8.(VH'3HC1NX#>DN]
M@,V'WCBM ZE+Q"PZ9[LZ1G!LB";5ALXU8H@*48JQZ%T!I&*WIK+[W]I*]$]T
M$E+'M=F@$2;-Q]AX^1][&\V7P5,63:*JM:%OB8@HI>K#<"JQ9(7(10=X5P I
M1#<T(LHOIQ_$T<CV;ZC@^L+0=M.6,7AK2HOMK2NXS<\+$:PK'E!R< <R$46]
M;"327M0]8V]53$AYZJ26QN\>>$>M&)9\:;M70,6 -6P]\^QK6?4>+ TN[%5H
M4U:)JH#V+DX1;"/%3YMQ),D&T=4-18KW#)VF1F35  ^X[>Z]#G3J$E$TF2CB
MHS7A]>K%4..88@M-4Z"IF162&RP31/MI>QPHADI,<XUWU 5S>S_P*,L:Z,@U
MCFS84SSJQ) THAHM13X7DRJ;0205;RV>C<G6QFBAJ2TTN^N%RF>9N;X3C*EP
MD(8TWM011RTT38&F#G</KSZ<I)U3LSC=IC%U(!'9M(BD5+BIV3B#'<BF0=0J
MUVJ;!P5GJYI$*=J9NP!&-;1JUXV;C$%7S/W!?H]X,8:.'HV$81B,TX:/PIC&
MHV  <OL6*)R-E=DXYC03<UQJ<(:UF4![8.&(BT( O/XHJ9F YM;'IG$D2\0R
M"O'@7=%.;8BXT6C9F71>5MYDN[X0^,+ C29!A+>%PYR,KN#3UO9.MW P>S,4
M6-8D(BI/'7;1_/VW)__\_=>B+"+-7WC0X5^ZX,.'M/'"6'"N%!DL]V(W^#5%
M4W>]/T7'G)F7NCDB6;"_8E+E"]F?+*O$>-[IM:5\+33U@J86.@M;&%:ZY]ZU
M")"((8I$+_:5>2DB3I=!0;U4 6ZQT3UF,5WLA>P/DS6QZU&A;J=54747PRTT
M]8YC+HD$G=(H>B=DZFLOIOQ)H")$>3^K7< WE;4]W;IJ$&5/"UTD<-L-L4YE
M+C66UBTT38&F!J[?TNEZ2U7J _.<*UB]+W*6'WBE&IR"9CXJG5>9Y?>4U-27
M@4X9FWE9CUX(M,BLYG/KNDHT]=$"PA:=U5Q\1<0X^R;0V5HH+33U@F;3%LKR
M2+0PH2$W+C"YPPG&X\ 7HCAP?A!X5>0ZO&>1ZR4Q'3P1=04Q4<;P8D^JD+;S
MU-2SBB"(&\PPK02"U),JM&K9,!:T"OV06E':0E-+:.H01'WUX0]FB="!8,/+
M<=:RG[#IE3D9BS(W$H(DCF(0L:PKXKH$;F4$8W]D<*JJ)/UNY\1-HF@Z,8L3
M&'8'D&JJ=6J@!81IF,0JIF=49(O2*?5SL]N+L\9G2U69#V^T\^&G7[;SX>LR
MZ;M!F]CWN?-'_<O?A<^G7_]H^B:74^/+F#O_K"+^=FSX.I#7#IE^QD8;,V2Z
MS+3X*XEB=WC_D-U99>F''J_!Q=FK#T=V-!*&7G"7EHS..A;:3NS>LL:J[^KH
MB=8+FHW4EJ7J1T?MLSS&N CH= SQP[<4N3&_%4)9V:_UU\ON9Y;D1#[XFL(%
MS$Y@7YKO6 7V[<>6^P.43:R,&V^R0^H$ON-Z5/"SH#.FC,'?'63M)*)8^=WR
M=8WXN@&]W]O.YNN,5QZ%=."FS+FE!B,Z]MQ5:U.J#>8@L58="K-#YCOQ;T'
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M=VQMW^,PS7#6[61(6[ U XH4$_/C9_]R43;<W* AB1L@.3D;C8+$&W"I.
M'C\A%()1X'&4(5V .1\P8P8,E>0:.").XI30ECHW(,/+?1M\:T\X YD5XF,,
M&9DTCZ( S5EX<&JAH$ $4D#)-\.'P+T+RJ4BTR"#()6&0_!&8G;RS,+,?KK0
MY&=J86;<D)XBUS[,(&0@1 ">9X=P-C[8=8.RPT'P"DSQ&>TJ&H(]3JLRQ90A
M ,=_48<Q\X "FH![4P3!FW+.4 BF,U-KW'"%'Z$!Q?P9#U#I#M&A2:=*T%LV
MWI-]Z89.,@9;$(YD@;)2$Z^"BY7GLBFM=3L,9WE*@)^ES$1+U5.1I9!D,OLY
MQ3ZN,@KN\GO/%HUFNBWGJJ$%'<Q<'7YCAAO,4YOK<WWZH".9>^6\*G:9&9]Q
MO ^F*C 7(G607<#"D][]/]/CR?:7>I%3L*=2@#NM#)(\!G&IO+O] +@]X0^0
MH !C.&=#\!Y[W<[R)PEN)SU.Y/)L!*P[I1]&8$N?SXR/,7 <N&#P>.S=YWEI
MB6!#Y9')*60!</[ (0&$YX1CZJ#/2:]Y^%I;9E?@+P+^P+V'U=Y[M/<>+8^M
M#G[J+78[)=$G,+.",.?\.2.7#G,Z=4 =%D,$T'^ \$0M.$G"29"VM()/\[\"
M&7S-KK@]+W"F2AD$LL/U?8R>2QJIXJ8$#Z&F.7UN.*>"A3\PF'-+9P4TY7HE
M%_NQF2'+%1U[([Q;F+X0]&]PUXKZ<O#7?#-S,7=08/X/!:PK.>'AYX-3%L6&
M UH:] 'B6/CLW2;O>;9V,;4Q35-E\Z^J);\\D..RM,8@N]^K7&=1]GB*S'SR
MXI+\]J.OB*_S?[V2Y45L5:JI>.!]5Z.04N$,OAA%PO%<0%M0)+*AK55/37KZ
MZ3P*PS8.3"J0]W,/#"\8-G4JC<7(ZN6(+9W."Y9U'\HE^/.A+5PFH'X 64VF
MV/7+W-^_M?C(XR.(6PIIN:?EGOIQSZ;+ %+#7D6[OKPX?\Z)6MQF^KC\>@G6
MYW\FE;ZD4/J4_EI?^'76 4%1B2$63+ '7U%.8SL _D FNH)=>E>#OPYX/Y
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MO:9LU%2G5D:1=Q^#PVLQ[C"8UU;F, .&Y,=Q_6S2G$6WGS1-,0>;M&TY/<R
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M ]3#3D<W$\RR]Q$,,?ZB93%F]<1W\<(AM;$9G"_1QCW= +7\Q(RB+=5_$P_
M>.&__Y9STL%AB@\(7HM=6%M,PC@$S&C=-4CB$G>$!Q&T9<\ \ #U=8UU^1S2
M'_%0[Y;E  =XO8\-K-ZA#*P3M0Q=.T#^P]%(WG-Y\CP(?9 ,G)G\?P,8I$(H
MK"V%GL%K+<O0GH6.!ZD <?)_%)8+0F"/(W!5JS8KY5BC66Q6&FN,1Z-2NJI7
MF]5*(U:LE5'E1^E+L79:0:6+\_-JHU&]J+U9(;PW7HI@U5;A&M.N;G:89>[$
MRLE2$BE2-I,_3+4*:X>2Y*,T$ILU1F$6^.?K9P]:[#)KK(S3V2=U\8?JVF<9
MEE7AFQ>JJH_"2BBNDXOZ><P;CONS/!C.2R<BVD\DRI;J\DB1)U9NU7$F8I*3
M^'WL?E?:QM7][@6$M:\-&?/!D#$X9[RPE_@Z'2*.EWXADONA++4@5W$%, 'A
M  -8K]2:L7KE\J+>7*!RW9!H422Z=!WJ8I/%F 7-5)ZP1G(:60Z2LUO:-K+:
MB'7)9R$=( Q(NH[.=$)CE8':Q2;8H*+*.*)R/IWY+)@NE$G?V9?A2:08T*-.
M;,MA:(M_YO0AV#& ;@R1!Y@3.>(QT;;W$?=^I@Q6?LI@78HL5,5+445;KMS/
MB[2F%\]+3'^1Y?*V>H[B^H#M:S!Z#]IV-3P< L#$#%LV68JR;"'@XH5S[*A=
MI&1W$)]FKK5;EJ^Z;#YDN&40X!O#@&]5OCT:AU7AGVVL:://+\8ED$08YP94
MRS"P30&<T5\B*7?(G)>/_T <IJO8&#$^B+>?X3MDVAO!7:Y'%R$>:5\\O'1\
MG71TRK<M&=\)B9:.A]QN^DOV9^[!?KU?)\NS6P'AN2%N+M:*]:)8U_-*N5DI
M?4'56BGY'"E@&O_'62Z%GPR#7ILJ6J38;54&L.0"=+[>7'LZXW5&F")J$Y5O
M(&A(![9@%($I!&7J;$<N9DJ(;&%]3,A&[3P!;EI9IM:1YFB=8DCK5$W5<L"&
MBS*)!@/35_+J"$J6-D<)_;[N77<[WW[^K,JO-=&\@H-O;S%B.]8#EXX9&ZW,
M:JE'88T7FF2 Z3-5U#3M?(HH?TS8-J+5FE!X+T3A$]T@L!HMXD23TV!4>R#6
M]YK<>;U-2<]2:S(OWSV5$^E\;G=O0YZ\E V1IXD'57\G616,_1BM&OA;LX.K
MK9OT[NMI%5$*, >(>"&;3R@*KU?+_"-L_]BTAJ+'V=AQH6Z"T&0\VK<@RG?0
M+PB-J::+-$#0>*(%_WP(LN #+6XP/6@/MF<3D"$E\9CB^'0L5;)Z/9W2S\A!
MW*P@3SUM;V@-M*[6&ZC2LPUK2)Q/1^VP54(U*SE#]/4-D![9NEK+..DM(5&$
MZ1^#F\G_$12NU:?JM,>W&_+XBIKF$$K]7V>Z2>1H;\].*SG9N&Y:N=<[>]E9
M9R]B_GA!5B1)4*_A@NE@J/A 3'>F -5GTATTC6'I"0R5: S[U:O.V;=A[U?]
M9=G>$(JYYZ"HQ L-5P<_*R,_RY7U%>@Z<UTFBB8E^//":5I],YHBYK5S_GU0
M2__J&Z^GR.Y<BDRF!TMN.5YV[!K^Z#Z;U>0HM(0/?>%<.M8#>(5S$A<E]_</
MHC]T+\M+S%OLS<5]"L87)"SLZ*CXC=HUJE N$&@O+1&X4$P\KR-H*CY TM)1
M+'EI :,8-[H]/Y.F#8\OV1GM?3_=>[VPY><R7 B">&$W)TO*RH3Q*Y.E]Q=+
MP ?AJ>V <.HV-A 9$-5E^@//W(,'2NCV8ECX7;/N*PSI%G"F@(VSYR?>\U@7
MV">;@/_]]YXB[Q[0&",&L;N629 I(NX=!,)AN#P 0=@A&+241B*W_G.^2N0&
MOP@MYRO![Y4S>X\<7[#>R[83@DI0">WH!^<$-MN3=[?GJ+T9YT+QP3ZS0']=
M<LP?2\?FOPRTXHUYT2J_ ?30=NSTO/%"5LDGE+0DO7L%PD94/B?L6^!W PO%
MO#UI1[BWQ$'8,X,@X6WDE62!P>!^*C(P'17Z;*\GRE'DFBVJ#I]AD9+9U^0%
MYY6=.7JGRQX[?+(N:QE9Y+Y&P-<L%BO:M@$.*K@6LZCXQ]R6A-(OES*]/5Q/
M7;0$X$M=HM[%6)<@;$-(#<XWWPMK60/4(H;5Y\J(/^0J"^TEOJ*V;G#?0Z?@
MB#!B:J"DF 5ZJN<:#)O$<JDQ1!0SG;:'HJ??P6H!"EX.V:NF#9;BN#".$\/F
M</2L;1DP.>_'PWR=[Z-0M$4)0:?$) [$!E43^KI>J6XQJ20]<+?W-\6 JU:5
MXP,!ZEPW%UL]("45,>8"U=.4-RKYWNBUHS/@=KZKYYK^7@B-=DF_MDV]X91^
ME;ZF7UT_V[(L@V!37$$PY:R&JG(BP>)KG-_-9 Z>.B#R!A(LS5PN0</YBQ13
M0ZN$;+_FGZLO?A +992LIXB$!II4R(O"^"UY%Y5.Z@@"@20TG+\'MG Q6H3$
M+$3L0H.L.K[3@GSL"W(#W$D5R&IVSL'.@;$SHJ7X_K=I_<@]7#8;V65(<:A:
M:Q:FIT7X'R*[DZ6)]?RUF15<.8,3LA*0W="1EK'D9J2DUW(CO"N.[SPK?.D0
M;NKXO33B)"1W/YV+=GM>=D@R<_?6X$LM2]1E"'&HC&\^;!MA]H49EBBA!M;H
M28LL9[2$LM7:?IYH>VTWPKWB^,[+4T\)4)52ESA/BOAUMU_;;=C'UN]E2'CV
M$0F? 7"I<O[^PLD!?5) TR21V5*?)Z!^VP_99]ID?:;\JLGY7R\-0QRBA>@[
M/@8M%+"?E@&:+BG!LCD*]>H2O^=< +60TH[TWD*+4IK\VM+1IC_!:A>I!J9T
M.54JP6K&]ZZM61Z!0EA)RZO17((&:CJ8B]C"BZ2?_],8]EJ6L47G%K%ON.XC
MU (__QS2"F3D48 UZG=U^&9BLE:S8FJ9&>G**)'E6?"AK+2$(HUVCT^O*TKV
M@;6TQNLKF)50>>_TO/$"=XHMTRM=9I9ZMX/^(R4E248V=M #-N86,2\H_EW!
MPJUE,L#H\**O0#TM-F<K(M>ZN\L.&NH;JAN54"EQ:%)P(\^;U0UQWTK<0K/K
M:;QYA=8CF1O%5O.OI_@[WS_!0X7]:+V,XM,5UESG1A57*WM1NB (%U?@5,/W
M\^J]2MC6&3;0.7;N"(M@EDU(^#' 5TV-!_HDUAHBE1<%<#CNP.(2<2AV:L=>
MIPCF)4#;#M^E[SA6GW5YOL#FN_B8(HVT==.[6,/;79.RHRAR:FO-NW,JC;;X
M\NT>B!TV*1L3C75Q)8?-K^3@E5)>TD%I)92(L:(NLAH/RA,0DWZ!89-K2JYE
M\!K?H1^A$$9 %$_Y7^DF/Q*X\"M[*SXOQ:9X:5Z!J%=H/^IU*CJ5O#[1NO%*
MKG[[W=Q3E,JK=>-CN<*(4P"1P#U[>W[Y_#A%4'FQM13KK0W;L?GZC1=A>\H2
MA96E/E/9U 552 RB,E"%IB4R:RXEHA4@X-=/\3?EZ"+;YKTE@+.<F,L8<H'H
MZS U%P43P(<G#GG0*?0#!8M-E6^)8E6\>X9#RE]3I&%'HU[EE#8OK9?>PN.T
M7E!S)M&8/=>2<&O-=1]_L7P@01"90 A</!^$_CTO.UX!C@K1AN-T +WO7;YW
M KT$@L*??ZK$.;#:3Q$R)_ACDK(.IJBG4]CA*6=SSU,YZEDVG&10GCRW:)"V
MZ#%=[C=[HY_P(6:W*D=^OE_W.[-N#L%WB18!E0CPV6*M@VN5>[J>.\ VD^GM
MT(1!1HWBT2<O7)@,N[3+4N.%!=[<<M@J5!GI(27)3R2.2[ 7.T.=4-=@E)N9
M"YLX_BXBV"=8ZY'I*EE@2OF#Y$PE^)HKB3<"_QR/S:^I71P:%V8L?.TJ-!6O
M:T/G1&L2>% UU23:XEX#/Z.F2 >^6RL^R0?;$!E2%YP.#/X'H12<%7"8P>/!
MI@DNBBIJQX$E)KZ+XS,)]WE@V-B]*ZY@%&S"[XY%GI-4)BKAY[%06A:099*H
M" K-'I>,!^#@)^>FIH>(K^TZIDZ['#8>+';UELY0/I^4N5\D8L*2ZSC\3EWO
MRMT8N$GCLG<.C:AY'UUX!,. [S=^3Q:"&)GHYD*CR0_A@$_"R#REIIOCUT_R
M-$0$B5& Q,&3E2'NF/ -IS&S=A#M8L,0[GR+((U E*"-I*&M&T3S92'&61J<
M;]NB1"C!L?.]]\STQ0YG5=SS)" H=,'&(\G;&=]@UH?P %&W]0OFBPGF)LC0
M<4LWO*G$Y!A<#P^>'4#%\9'2@SC-YW983AZ0^&<[YE9-^ZF=G=@$#0'E=-"Q
MPS=YB"WN9"4#(;G\% EA7"M \ /341>4CS??,H0LQ(CK92W>WVG()R5Y:4[#
MQ#40UW7P6B3/9_"%DFX<A8^+3UN%+6T[-J+$>QU#?"<RK&4]T,ON[%Q -<#X
M[-7N>VA*X#B?VP1&-2OYU$VU/JW&J,J!#(B4E)\X@[:X=5K^PI0)51W=]JXI
M78_;8Y:P$-Q'B^*'Q9PT7#85,?)>T$L&^7Q"3G993Y3B0N12'T<N(IX*AV5H
M:^*5!M.[XYB>[VOA?RI+R%)F;3FB9,%:"^A$'JK*"V&Q*BY!*F.&D;A]=8N'
MPAH/"OC>@(AM>%-PC@GZ<5P_0YK_2I7 ]F;4UOJK,UR/I#^53?KSTZ4_5]V;
M^QROKFQ43VO%YE6=O_#U4SG6[[F)O?!,4O#=<-[F[KVK.WY<^MPT3L2NL.8:
M0Z1BE^_DBM24=\$/M^(M@BB@" \L[[4T+=+%1ANUAN*B#I%N\1OPE)1K0A\Q
M''99UW( >&U)92V;$.P]W",?W.Q"ZZKY2]7V'PN<7@Q?9K$ "@]7 #5YY]L"
MH5TLL(N\Y'$YRSD+X>I$ *M)B0U4JP+5AE-7 BHPC/S;H[CR8IN[:-=8;$)[
MKT.<;$1S-SDZP-WPS0:JE89JPZG_=*B.AX]ZXXO:B%BH(M8+*9KRM+ .82XQ
M4#F)SM4:T8W#E+ZBZ>;/STJK"14_#;:0@!-"PUENV[#8VD(ES@WOK_@V3%<G
M[5AQ<J[B0KR!PBM+% ]14>OIILCHB=V948/-6<97 __DWE+Z %V(_6ZZC\[X
MI>B;K:8W;C6M^\Y/%)L&<&H0H*\P1&B@#0Y0M2S^N)7VCF_%^2OO9FF.M.A&
M_AZ<_+JJ?.W_*GZK7Z6^7?0'-PU)ND__J-M7]5.G<7PR./U+ONKTE%[S].Q[
M-6V<_<S03+GXNYSZ*Y^J-F[T^M5#LWI>LW]T;_K]LQN'552+7MV<DKTOG6&-
MM,KG5;9W?:_>*.G\WN5NT2Q^+7>NS%]_EZ4O/UME9= [_=ZY&=2,FW[OJ]J1
MKOJ.<CTXR>=O!K35N)?2;N>4?94[O_.-P3><RM8:/]7\W^>4X;^Z.>L7+=?N
MSK^7!E_^^J;\_;UHTON:>IFQW;)%NR>UX[M>17=[9*"I>D[[\M?P>U>Z+K9R
M;%!-_6[GBL5OK&%UCKP52;4L;<A_=UG/*/P?4$L#!!0    ( *\X>5I3ZU=2
M+P,  /(+   1    <VUT:2TR,#(U,#,R-2YX<V2U5MMRVC 0?>],_T'U:\<V
MEY & NFTI.G0@203R&7ZTA'V AIDR95D(/WZ2KYP,[A 6S_)JW/.[FIW93<_
M+@**9B DX:QEE9V2A8!YW"=LW+(>^_:G?KO3L=#'J[=OD'Z:[VP;W1"@?@-=
M<\_NL!&_1+<X@ ;Z"@P$5EQ<HB=,(V/A-X2"0&T>A!04Z(W$4P/5G$IMB&S[
M -TG8#X7CP^=I>Y$J5 V7'<^GSN,S_"<BZET/!X<)MA76$5RJ59:E-+G,'J/
M2&])KI_W0OEA\4!>QL NHFO,YO(9O__V/+RO_ZI]O^C#=#)[_EP=/C$L7K],
M:]Z,WK=O[GJ#V^!LX-TE+IO2FT" D2X&DRW+Y)>F-Z\Z7(S=2JE4=E]ZW7Z,
MLQ)@8T$)F^Z"E^OUNAOO9M <<C$4-).NNF9[B"4LE?4N*< 3)A5FW@;>5TO"
M.KCF)IL;4+(3>IY 20;U80LGP7/&?.;J#8VOG&7 2-ICC,,E>(3E,!9--S;
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MOU]>WW0M/\G->I/\:X53(K?\%U!+ P04    " "O.'E:97S(5EP'  #?5P
M%0   '-M=&DM,C R-3 S,C5?<')E+GAM;,V<WU/;.!#'WV_F_@=?[CF$A-([
M*%P'4M+)E!:.T/;N7CJ*K20:9"DCR23Y[T^RXS0_+'EY\<(#!&<E[?>SLNRU
M)%^\7Z8\>J9*,RDN6]VCXU9$12P3)J:7K:^C]M6H/QRV(FV(2 B7@EZVA&R]
M_^O77R+[<_%;NQT-&.7)>?1!QNVAF,AWT1>2TO/H(Q54$2/5N^@;X9D[(@>,
M4Q7U93KGU%#[1='P>71ZU#L=1^TVH-YO5"12?7T8;NJ=&3/7YYW.8K$X$O*9
M+*1ZTD>Q3&$5C@PQF=[4=KP\7O\4Q2\X$T_G[M>8:!I97D*?+S6[;+EVU\TN
M3HZDFG9ZQ\?=SC^?;T?QC*:DS83C%M-66<K54E6N>W9VULF_+4T/+)=CQ<LV
M3CJE.YN:[;<L8+_EB6;G.G?O5L;$Y&&O;2;R6KC_VJ59VQUJ=WOMD^[14B>M
M$GY.4$E.'^@D<G]M]#:M:B*(LH%(#(UG+FH=9]'I2]LKK;MYV9FBD\N63@VS
M3?1.CT]ZIZZ!WW>,S&IN>Z=FKG.UHLY.XW-%-14FUWMK#^P4H4MC^Q1-RHI<
M^R]RSS#C2JR[33=JNSZ6I;9!^[&P7'M3^L-EO.,"=[&0>WK+?IT3US0^FLKG
M3D*9)=][XSXX&&]R$/:?'WE#5V-M%(E-61,G8\KS^G]8FSV33@->E20>;8W5
M3NU:[/NT';DK%4=2)519UF5=1,4[\3KLHFN+SIPH6U$[GC&^"?5$R=1'9TU"
M>AS=!F6;:(;FE6T_<3X,.)E6X]PS ?+L8@"M5(-%] /5L6)SQZ4&[(XED&\/
ME6^%MH8QE^?. YTRYZ]SQ5UXJ3L8'A<\18#@3S!'BJ!:I A<"9$1_D#G4M6
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MJ7_U0K4E%#!*IA<2AS;V3D%C[_2%8R]*QN<3A<2V6!MNSZB[,6=3XM])%BP
MWF>#23P@M>G]>_F6'[>?6Z6Y'P/[H1J[QQ0*'&>+9$A>TZBSA!F:%"X-F" B
MMBG59E^;)SNO+P4- ,X>2J!HE,?[WRGGGX1<B!$E6@J:%+?ZH2?\WB+0*"#.
M(=;(10G!-\DS2TGE"T&5YQSPF$*1(\X=>N3AK+TL%C5OKCW%BSM"Q'TEH. 1
M)Q'#8I'6IQGJ?&;/] ,Q9.UAB+^O!)0_XH1B6"S:^GG5MQ>>J0S/F>\90FDC
M+H6ME(8">902SJ\SS035P;%ESQ *&7'-:Z4T%,@W*553.ZA]5')A9NN]G2'8
MG@)0Z(@K6X-2<> O?^XC+_:_!<E76(/?3H"(W2L2Z[4;<>P64A17<I$0Y:$>
MLH=R1]U8Z1?:,/D[,Z-J^_XI=V9H\[;0HH?Z4M HH*2K4-$XU]:MG?S!2^N.
M'90W8F):)0QGSU0VYBP><$F"]^4[9E"^B%EHA2P4O-=$/*EL;N+5O9(QI6[Z
M1&_.-D!"!*P &A+$_/1%*' >%\@T=9N)9/PTFEG1^BXS^7M,K7_!AP;!<M#0
M8&[B! A'N@O2/S=ZT>1Z]4 G5+EE"H]T::YM0T_AFR) <6A\4-\H!,90$::+
MSH&N6WO O:FV^,;]<F]CM4?^!U!+ 0(4 Q0    ( *\X>5JO%S<[ZCX  .H#
M P *              "  0    !E>#DY+3$N:'1M4$L! A0#%     @ KSAY
M6D])S.S8$P  VY\   L              ( !$C\  &9O<FTX+6LN:'1M4$L!
M A0#%     @ KSAY6E/K5U(O P  \@L  !$              ( !$U,  '-M
M=&DM,C R-3 S,C4N>'-D4$L! A0#%     @ KSAY6B'+R6;^"@  @(8  !4
M             ( !<58  '-M=&DM,C R-3 S,C5?;&%B+GAM;%!+ 0(4 Q0
M   ( *\X>5IE?,A67 <  -]7   5              "  :)A  !S;71I+3(P
D,C4P,S(U7W!R92YX;6Q02P4&      4 !0 V 0  ,6D

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="smti-20250325.xsd" xlink:type="simple"/>
    <context id="AsOf2025-03-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000714256</identifier>
        </entity>
        <period>
            <startDate>2025-03-25</startDate>
            <endDate>2025-03-25</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-03-25" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-03-25" id="Fact000004">0000714256</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-03-25" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-03-25" id="Fact000010">2025-03-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-03-25" id="Fact000011">SANARA     MEDTECH INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-03-25" id="Fact000012">TX</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-03-25" id="Fact000013">001-39678</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-03-25" id="Fact000014">59-2219994</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-03-25" id="Fact000015">1200     Summit Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-03-25" id="Fact000016">Suite 414</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-03-25" id="Fact000017">Fort     Worth</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-03-25" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-03-25" id="Fact000019">76102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-03-25" id="Fact000020">(817)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-03-25" id="Fact000021">529-2300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-03-25" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-03-25" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-03-25" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-03-25" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-03-25" id="Fact000026">Common     Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-03-25" id="Fact000027">SMTI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-03-25" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-03-25" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
